After treating 18 months, a child heal a rare cancerous tumor in Abu Dhabi

The three -and -a -half -year -old child, Mahmoud, faced great health challenges, after a series of tests revealed a diagnosis of cancer and nerve tumor, which is a rare form of child cancer that affects children under the age of five mainly, and he underwent a series of long treatments that included treatment Chemical, surgery, bone marrow transplant, radiotherapy and immunotherapy, even in good health.

The tireless efforts made by the medical staff in Burjeel Medical City led (BMC) Which included more than 14 specializations for more than a year and a half, in addition to understanding and supporting his family and the advanced health care infrastructure in the UAE, to change the life of the child Mahmoud, the medical team of this fierce type of cancer to help the young man restore his life.

The child’s father, Mahmoud, said: “The months before the diagnosis were full of doubts and fears, as Mahmoud suffered from many symptoms such as constipation, high fever, general weakness, difficulty breathing, lack of desire to move and constant crying, and in the case of Mahmoud, the tumor grew to become near the back of his right lung, And wrapping around the spinal cord “.

He added: “After overcoming the initial shock, we were informed that Mahmoud’s treatment will include multiple stages, including chemotherapy to reduce the tumor, surgery to remove the remaining tumor, radiotherapy, bone marrow transplant, and immunotherapy, and after a long search the family decided to put Mahmoud in a city Burjil Medical BMC To obtain treatment in it due to comprehensive and multi -media treatment options for child cancer patients under one roof.

Comprehensive and developed care

Dr. Zine El Abidine, a consultant and head of the Department of Hematology and Oncology and Orthopedic Cultivation in Children, supervised the treatment of Mahmoud, and the medical team was planned to apply a therapeutic protocol that includes advanced technology and personal methods to maximize the chances of recovery.

The Diagnosis and Treatment Journey in August 2023 began with a molecular genetic test in ONCOHELIX CO-LabAnd, which provided detailed genetic information to improve Mahmoud treatments and allocate them according to his condition, then underwent four sessions of chemotherapy to reduce the size of the tumor, followed by a complex surgery to remove it, while the tumor, located near his lung and spinal cord, was great challenges, but surgery was successfully conducted, The last chemotherapy session for Mahmoud was completed in November 2023, and in the following month of the same year, Mahmoud underwent the bone marrow transplant, during the period between February to March 2024, Mahmoud received 12 sessions of radiotherapy, and from June 2024 to January 2025, Mahmoud underwent immune therapy sessions aimed at fighting any remaining cancerous cells.